Skip to main content

Hyris' Partners

Hyris System™ allows a wide range of operators and researchers to develop their own assays and kits.


About Us

Hyris is a tech-bio company committed to democratise genetics and health insights.


Hyris History.

From life to knowledge

Our History

Throughout its history, Hyris constantly evolved its supply chain, always staying true to its Mission: striving to offer the most flexible solution available in the genetic analysis market.

20+Years of Experience

With 20+ years of experience in cooperating with the major players in biomedical systems, Hyris Founders contributed in developing and transitioning to manufacturing some of the best-known products in the field.

A unique path

Upon its foundation, Hyris established its own niche, moving away from both the ‘standard-but-not so flexible’ solutions and the most ‘experimental-but not-so-reliable’ applications that were available on the market.

Versatile solutions

From Botanicals to Nutraceuticals, from Human Diagnostics to Immunology, Hyris has always been expanding in different industries, providing cutting-edge solutions wherever health is at risk.

Today, Hyris is strengthened by the experience of its leaders in commercializing high-tech products to offer the deployment and implementation of targeted commercial strategies for its partners and clients via business-wise account management and highly reliable technical support for clients ranging from small research centres to Fortune-500 global corporations.

Today, Hyris is strengthened by the experience of its leaders in commercializing high-tech products to offer the deployment and implementation of targeted commercial strategies for its partners and clients via business-wise account management and highly reliable technical support for clients ranging from small research centres to Fortune-500 global corporations.

Hyris Timeline


October 2014

Hyris Ltd founded in London, UK


July 2015

R&D facilities open in Milan, Italy


January 2016

The HYRIS bCUBE™ 1.0 completes the first successful run.


April 2016

First client orders are booked, third-party integration activities start.


May 2016

Key customer demos and technical co-development.
First commercial revenues are booked.


October 2016

Hyris obtains the Seal of Excellence of the European Commission.


May 2017

Hyris announces partnership and entry into the Botanicals application area.


August 2017

HYRIS bCUBE™ 2.0 is available for sale.


April 2019

Hyris launches its product line for Probiotics strains identification.


April 2020

Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.


June 2020

Hyris receives Series-A funding.


September 2020

Entrance in the healthcare sector, with CE-IVD marking and Health Canada approval for SARS-CoV-2 human specimend test.


September 2021

Hyris presents its new Brand Identity, supporting its fast growth worldwide.


November 2021

HYRIS bCUBE 3™ is available for sale.


December 2021

Hyris obtains ISO9001 and ISO13485 certifications.


February 2022

Hyris obtains IS27001 certification.


September 2022

First marketplace applications in product catalog.

Hyris Timeline


October 2014

Hyris Ltd founded in London, UK


July 2015

R&D facilities open in Milan, Italy


January 2016

The HYRIS bCUBE™ 1.0 completes the first successful run.


April 2016

First client orders are booked, third-party integration activities start.


May 2016

Key customer demos and technical co-development.
First commercial revenues are booked.


October 2016

Hyris obtains the Seal of Excellence of the European Commission.


May 2017

Hyris announces partnership and entry into the Botanicals application area.


August 2017

HYRIS bCUBE™ 2.0 is available for sale.


April 2019

Hyris launches its product line for Probiotics strains identification.


April 2020

Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.


June 2020

Hyris receives Series-A funding.


September 2020

Entrance in the healthcare sector, with CE-IVD marking and Health Canada approval for SARS-CoV-2 human specimend test.


September 2021

Hyris presents its new Brand Identity, supporting its fast growth worldwide.


November 2021

HYRIS bCUBE 3™ is available for sale.


December 2021

Hyris obtains ISO9001 and ISO13485 certifications.


February 2022

Hyris obtains IS27001 certification.


September 2022

First marketplace applications in product catalog.

"Throughout our history, we constantly strived to evolve Hyris’ supply chain, staying true to our Mission: striving to offer the most flexible and accessible solutions in the genetic analysis market."

Stefano Lo Priore

Founder & CEO

#WEAREHYRIS

"Throughout our history, we constantly strived to evolve Hyris’ supply chain, staying true to our Mission: striving to offer the most flexible and accessible solutions in the genetic analysis market."

Stefano Lo Priore

Founder & CEO

#WEAREHYRIS


"Throughout our history, we constantly strived to evolve Hyris’ supply chain, staying true to our Mission: striving to offer the most flexible and accessible solutions in the genetic analysis market."

Stefano Lo Priore

Founder & CEO

#WEAREHYRIS


Discover how Hyris can help you perform beyond your current diagnostics capabilities.